What is the current annual D&A of GSK?

As of today, GSK annual D&A is $3.05B

What is 1-year change in GSK annual D&A?

GSK annual D&A is down -6.45% year-over-year

What is 3-year change in GSK annual D&A?

GSK annual D&A is up +15.31% over the past 3 years

How far is GSK annual D&A from its all-time high?

GSK annual D&A is currently -6.45% below its historical high of $3.26B set on December 31, 2024

How does GSK annual D&A rank versus sector peers?

GSK annual D&A is higher than 98.61% of companies in Healthcare sector

When is GSK next annual earnings release?

As of today, the next annual earnings release for GSK has not been scheduled

What is the current quarterly D&A of GSK?

As of today, GSK quarterly D&A is $297.10M

What is GSK quarterly D&A most recent change?

GSK quarterly D&A was down -52.38% on June 30, 2026

What is 1-year change in GSK quarterly D&A?

GSK quarterly D&A is down -80.51% year-over-year

How far is GSK quarterly D&A from its all-time high?

GSK quarterly D&A is currently -91.33% below its historical high of $3.43B set on December 31, 2020

How does GSK quarterly D&A rank versus sector peers?

GSK quarterly D&A is higher than 97.10% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on October 28, 2026

What is the current TTM D&A of GSK?

As of today, GSK TTM D&A is $3.36B

What is GSK TTM D&A most recent change?

GSK TTM D&A was down -26.76% on June 30, 2026

What is 1-year change in GSK TTM D&A?

GSK TTM D&A is down -31.61% year-over-year

How far is GSK TTM D&A from its all-time high?

GSK TTM D&A is currently -43.56% below its historical high of $5.95B set on September 30, 2021

How does GSK TTM D&A rank versus sector peers?

GSK TTM D&A is higher than 98.86% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on October 28, 2026

GSK Plc (GSK) Depreciation And Amortization History & Chart

Annual D&A

$3.05B$210.10M-6.45%

December 31, 2025

Summary

Current Value: As of today, GSK annual D&A is $3.05B, down -6.45% on December 31, 2025
Historical Performance: GSK annual D&A is up +15.31% over the past 3 years, up +1.15% over the past 5 years
All-Time High Comparison: GSK annual D&A is currently -6.45% below its historical high of $3.26B set on December 31, 2024
3-Year Low Comparison: GSK annual D&A is +15.31% above its 3-year low of $2.64B reached on an earlier date
Sector Comparison: GSK annual D&A is higher than 98.61% of companies in Healthcare sector

Depreciation & Amortization Chart

beforeafter

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual D&A	Dec 31, 25	$3.05B	-6.5%	+15.3%	+1.1%	+17.7%
Quarterly D&A	Jun 30, 26	$297.10M	-80.5%	-48.2%	-61.1%	-60.5%
TTM D&A	Jun 30, 26	$3.36B	-31.6%	+38.6%	-38.9%	+56.8%
Price	Aug 13, 26	$50.45	+28.9%	+42.8%	+17.9%	+19.8%
Annual SG&A	Dec 31, 25	$1.24B	+389.6%	+423.8%	+136.8%	-93.8%
Annual Total Expenses	Dec 31, 25	$35.52B	-3.5%	+16.0%	-2.3%	-14.0%
Annual Operating Expenses	Dec 31, 25	$21.78B	+5.0%	+38.4%	+13.7%	-10.1%
Annual Revenue	Dec 31, 25	$43.05B	+7.4%	+19.2%	-1.5%	-1.8%

Depreciation & Amortization Highs

GSK Annual D&A Highs Comparison
Period	High	Date	Current
3Y	$3.26B	Dec 31, 24	-6.5%
5Y	$3.26B	Dec 31, 24	-6.5%
All	$3.26B	Dec 31, 24	-6.5%

Depreciation & Amortization Lows

GSK Annual D&A Lows Comparison
Period	Low	Date	Current
3Y	$2.64B	N/A	+15.3%
5Y	$2.64B	Dec 31, 22	+15.3%
All	$279.40M	Jun 30, 91	+991.5%

Depreciation & Amortization History

Year	Value	Change
2025	$3.05B	-6.4%
2024	$3.26B	+14.3%
2023	$2.85B	+7.8%
2022	$2.64B	-9.4%
2021	$2.92B	-3.2%
2020	$3.01B	+1.3%
2019	$2.98B	+20.3%
2018	$2.47B	-0.0%
2017	$2.48B	+3.7%
2016	$2.39B	-4.1%
2015	$2.49B	+1.9%
2014	$2.44B	+10.3%
2013	$2.21B	-3.3%
2012	$2.29B	+0.4%
2011	$2.28B	-12.0%
2010	$2.59B	+5.7%
2009	$2.45B	+8.2%
2008	$2.27B	+10.8%

Year	Value	Change
2007	$2.05B	+16.0%
2006	$1.76B	+7.4%
2005	$1.64B	+4.4%
2004	$1.57B	+12.0%
2003	$1.40B	+11.2%
2002	$1.26B	+8.2%
2001	$1.17B	-0.1%
2000	$1.17B	+2.5%
1999	$1.14B	+85.9%
1998	$613.19M	+0.4%
1997	$610.84M	-4.5%
1996	$639.67M	-24.0%
1995	$841.17M	+99.2%
1994	$422.21M	+16.7%
1993	$361.84M	+7.8%
1992	$335.72M	+20.2%
1991	$279.40M	-

FAQ

What is the current annual D&A of GSK?: As of today, GSK annual D&A is $3.05B
What is 1-year change in GSK annual D&A?: GSK annual D&A is down -6.45% year-over-year
What is 3-year change in GSK annual D&A?: GSK annual D&A is up +15.31% over the past 3 years
How far is GSK annual D&A from its all-time high?: GSK annual D&A is currently -6.45% below its historical high of $3.26B set on December 31, 2024
How does GSK annual D&A rank versus sector peers?: GSK annual D&A is higher than 98.61% of companies in Healthcare sector
When is GSK next annual earnings release?: As of today, the next annual earnings release for GSK has not been scheduled

Quarterly D&A

$297.10M$326.74M-52.38%

June 30, 2026

Summary

Current Value: As of today, GSK quarterly D&A is $297.10M, down -52.38% on June 30, 2026
Historical Performance: GSK quarterly D&A is down -80.51% year-over-year, down -48.17% over the past 3 years
All-Time High Comparison: GSK quarterly D&A is currently -91.33% below its historical high of $3.43B set on December 31, 2020
3-Year Low Comparison: GSK quarterly D&A is at its 3-year low
Sector Comparison: GSK quarterly D&A is higher than 97.10% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly D&A	Jun 30, 26	$297.10M	-52.4%	-80.5%	-48.2%	-61.1%
Annual D&A	Dec 31, 25	$3.05B	–	-6.5%	+15.3%	+1.1%
TTM D&A	Jun 30, 26	$3.36B	-26.8%	-31.6%	+38.6%	-38.9%
Price	Aug 13, 26	$50.45	-1.1%	+28.9%	+42.8%	+17.9%
Quarterly SG&A	Jun 30, 26	$2.96B	+3.5%	+3.4%	+4.1%	+25.1%
Quarterly Total Expenses	Jun 30, 26	$10.70B	+34.8%	+22.5%	+53.9%	+65.6%
Quarterly Operating Expenses	Jun 30, 26	$5.25B	+8.9%	+7.0%	+17.5%	+35.5%
Quarterly Revenue	Jun 30, 26	$11.29B	+9.8%	+5.9%	+25.6%	+38.3%

Quarterly D&A Highs

GSK Quarterly D&A Highs Comparison
Period	High	Date	Current
1Y	$1.52B	N/A	-80.5%
3Y	$1.52B	Jun 30, 25	-80.5%
5Y	$1.52B	Jun 30, 25	-80.5%
All	$3.43B	Dec 31, 20	-91.3%

Quarterly D&A Lows

GSK Quarterly D&A Lows Comparison
Period	Low	Date	Current
1Y	$297.10M	Jun 30, 26	at low
3Y	$297.10M	Jun 30, 26	at low
5Y	-$74.64M	Dec 31, 22	+498.0%
All	-$1.47B	Jun 30, 20	+120.2%

Quarterly D&A History

Month	Value	Change
Jun 2026	$297.10M	-52.4%
Mar 2026	$623.84M	-55.1%
Dec 2025	$1.39B	+32.4%
Sep 2025	$1.05B	-31.2%
Jun 2025	$1.52B	+47.0%
Mar 2025	$1.04B	-9.0%
Dec 2024	$1.14B	-6.0%
Sep 2024	$1.21B	+50.4%
Jun 2024	$805.25M	+15.7%
Mar 2024	$696.10M	-51.3%
Dec 2023	$1.43B	+91.9%
Sep 2023	$744.57M	+29.9%
Jun 2023	$573.18M	-26.3%
Mar 2023	$777.63M	+1,141.8%
Dec 2022	-$74.64M	-106.5%
Sep 2022	$1.15B	-2.4%
Jun 2022	$1.17B	+109.5%
Mar 2022	$560.55M	+43.1%
Dec 2021	$391.59M	-69.0%
Sep 2021	$1.26B	+65.4%
Jun 2021	$763.15M	+53.3%
Mar 2021	$497.78M	-85.5%
Dec 2020	$3.43B	+324.6%
Sep 2020	$807.17M	+154.9%
Jun 2020	-$1.47B	-693.0%
Mar 2020	$247.87M	+213.9%
Dec 2019	-$217.67M	-135.5%
Sep 2019	$613.04M	-39.5%
Jun 2019	$1.01B	-34.2%
Mar 2019	$1.54B	+68.2%
Dec 2018	$916.03M	+43.0%
Sep 2018	$640.54M	+137.6%
Jun 2018	$269.56M	-59.5%
Mar 2018	$665.18M	+409.4%
Dec 2017	-$215.02M	-123.8%
Sep 2017	$904.38M	-34.2%
Jun 2017	$1.37B	+240.3%
Mar 2017	$403.96M	-49.3%
Dec 2016	$797.42M	+246.2%
Sep 2016	$230.30M	-59.5%
Jun 2016	$569.25M	-28.0%
Mar 2016	$790.39M	+79.7%
Dec 2015	$439.76M	+21.5%
Sep 2015	$361.95M	-59.2%
Jun 2015	$886.29M	+9.1%
Mar 2015	$812.70M	+244.4%
Dec 2014	$235.97M	-62.5%
Sep 2014	$629.96M	-1.2%
Jun 2014	$637.41M	-33.1%
Mar 2014	$952.41M	+258.8%
Dec 2013	-$599.76M	-153.9%
Sep 2013	$1.11B	+33.1%
Jun 2013	$835.57M	-3.6%

Month	Value	Change
Mar 2013	$866.92M	-21.4%
Dec 2012	$1.10B	+165.6%
Sep 2012	$415.03M	+4.5%
Jun 2012	$397.00M	+5.3%
Mar 2012	$377.07M	-4.0%
Dec 2011	$392.72M	-58.1%
Sep 2011	$937.31M	+24.5%
Jun 2011	$753.01M	+261.5%
Mar 2011	$208.29M	-30.7%
Dec 2010	$300.70M	-65.8%
Sep 2010	$880.07M	+27.6%
Jun 2010	$689.76M	-4.3%
Mar 2010	$721.01M	+42.3%
Dec 2009	$506.76M	-35.8%
Sep 2009	$788.84M	+170.7%
Jun 2009	$291.43M	-66.3%
Mar 2009	$864.38M	+158.0%
Dec 2008	$335.03M	-54.9%
Sep 2008	$743.52M	+30.2%
Jun 2008	$570.84M	-7.4%
Mar 2008	$616.35M	+173.4%
Dec 2007	$225.41M	-71.7%
Sep 2007	$795.92M	+60.4%
Jun 2007	$496.25M	-7.3%
Mar 2007	$535.50M	+420.9%
Dec 2006	$102.80M	-82.7%
Sep 2006	$594.52M	-10.3%
Jun 2006	$662.51M	+63.0%
Mar 2006	$406.44M	-9.7%
Dec 2005	$450.23M	+6.4%
Sep 2005	$423.25M	-14.1%
Jun 2005	$492.77M	+77.3%
Mar 2005	$277.96M	+308.0%
Dec 2004	-$133.62M	-122.7%
Sep 2004	$589.10M	+8.4%
Jun 2004	$543.35M	-5.5%
Mar 2004	$575.00M	+152.2%
Dec 2003	$228.01M	-63.2%
Sep 2003	$619.59M	+109.3%
Jun 2003	$296.00M	+13.3%
Mar 2003	$261.25M	+4.6%
Dec 2002	$249.87M	-36.2%
Sep 2002	$391.83M	+62.2%
Jun 2002	$241.50M	-32.0%
Mar 2002	$355.16M	-8.6%
Dec 2001	$388.41M	+19.1%
Sep 2001	$326.19M	+35.1%
Jun 2001	$241.51M	+12.5%
Mar 2001	$214.63M	-80.7%
Dec 2000	$1.11B	+608.7%
Sep 2000	-$219.01M	-236.1%
Jun 2000	-$65.17M	-122.9%
Mar 2000	$284.19M	-

FAQ

What is the current quarterly D&A of GSK?: As of today, GSK quarterly D&A is $297.10M
What is GSK quarterly D&A most recent change?: GSK quarterly D&A was down -52.38% on June 30, 2026
What is 1-year change in GSK quarterly D&A?: GSK quarterly D&A is down -80.51% year-over-year
How far is GSK quarterly D&A from its all-time high?: GSK quarterly D&A is currently -91.33% below its historical high of $3.43B set on December 31, 2020
How does GSK quarterly D&A rank versus sector peers?: GSK quarterly D&A is higher than 97.10% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on October 28, 2026

TTM D&A

$3.36B$1.23B-26.76%

June 30, 2026

Summary

Current Value: As of today, GSK TTM D&A is $3.36B, down -26.76% on June 30, 2026
Historical Performance: GSK TTM D&A is down -31.61% year-over-year, up +38.63% over the past 3 years
All-Time High Comparison: GSK TTM D&A is currently -43.56% below its historical high of $5.95B set on September 30, 2021
3-Year Low Comparison: GSK TTM D&A is +66.19% above its 3-year low of $2.02B reached on September 30, 2023
Sector Comparison: GSK TTM D&A is higher than 98.86% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM D&A	Jun 30, 26	$3.36B	-26.8%	-31.6%	+38.6%	-38.9%
Annual D&A	Dec 31, 25	$3.05B	–	-6.5%	+15.3%	+1.1%
Quarterly D&A	Jun 30, 26	$297.10M	-52.4%	-80.5%	-48.2%	-61.1%
Price	Aug 13, 26	$50.45	-1.1%	+28.9%	+42.8%	+17.9%
TTM SG&A	Jun 30, 26	$57.71B	+371.4%	+317.7%	+438.4%	+332.9%
TTM Revenue	Jun 30, 26	$44.55B	+1.4%	+8.8%	+26.3%	+8.4%

TTM D&A Highs

GSK TTM D&A Highs Comparison
Period	High	Date	Current
1Y	$5.00B	Dec 31, 25	-32.8%
3Y	$5.00B	Dec 31, 25	-32.8%
5Y	$5.95B	Sep 30, 21	-43.6%
All	$5.95B	Sep 30, 21	-43.6%

TTM D&A Lows

GSK TTM D&A Lows Comparison
Period	Low	Date	Current
1Y	$3.36B	Jun 30, 26	at low
3Y	$2.02B	Sep 30, 23	+66.2%
5Y	$2.02B	Sep 30, 23	+66.2%
All	-$826.51M	Jun 30, 20	+506.3%

TTM D&A History

Month	Value	Change
Jun 2026	$3.36B	-26.8%
Mar 2026	$4.59B	-8.3%
Dec 2025	$5.00B	+5.3%
Sep 2025	$4.75B	-3.3%
Jun 2025	$4.91B	+17.1%
Mar 2025	$4.19B	+8.8%
Dec 2024	$3.85B	-7.0%
Sep 2024	$4.14B	+12.7%
Jun 2024	$3.68B	+6.7%
Mar 2024	$3.44B	-2.3%
Dec 2023	$3.52B	+74.4%
Sep 2023	$2.02B	-16.6%
Jun 2023	$2.42B	-19.9%
Mar 2023	$3.02B	+7.7%
Dec 2022	$2.81B	-14.2%
Sep 2022	$3.27B	-3.4%
Jun 2022	$3.39B	+13.8%
Mar 2022	$2.98B	+2.2%
Dec 2021	$2.91B	-51.0%
Sep 2021	$5.95B	+8.3%
Jun 2021	$5.50B	+68.4%
Mar 2021	$3.26B	+8.3%
Dec 2020	$3.01B	+576.4%
Sep 2020	-$632.38M	+23.5%
Jun 2020	-$826.51M	-149.9%
Mar 2020	$1.66B	-43.8%
Dec 2019	$2.95B	-27.8%
Sep 2019	$4.08B	-0.7%
Jun 2019	$4.11B	+22.1%
Mar 2019	$3.37B	+35.1%
Dec 2018	$2.49B	+83.1%
Sep 2018	$1.36B	-16.2%
Jun 2018	$1.62B	-40.5%
Mar 2018	$2.73B	+10.6%
Dec 2017	$2.47B	-29.1%
Sep 2017	$3.48B	+24.0%
Jun 2017	$2.81B	+40.3%
Mar 2017	$2.00B	-16.2%
Dec 2016	$2.39B	+17.6%
Sep 2016	$2.03B	-6.1%
Jun 2016	$2.16B	-12.8%
Mar 2016	$2.48B	-0.9%
Dec 2015	$2.50B	+8.9%
Sep 2015	$2.30B	-10.4%
Jun 2015	$2.56B	+10.7%
Mar 2015	$2.32B	-5.7%
Dec 2014	$2.46B	+51.6%
Sep 2014	$1.62B	-22.9%
Jun 2014	$2.10B	-8.6%
Mar 2014	$2.30B	+3.9%
Dec 2013	$2.21B	-43.5%
Sep 2013	$3.92B	+21.6%
Jun 2013	$3.22B	+15.8%

Month	Value	Change
Mar 2013	$2.78B	+21.4%
Dec 2012	$2.29B	+44.9%
Sep 2012	$1.58B	-24.8%
Jun 2012	$2.10B	-14.5%
Mar 2012	$2.46B	+7.4%
Dec 2011	$2.29B	+4.2%
Sep 2011	$2.20B	+2.7%
Jun 2011	$2.14B	+3.0%
Mar 2011	$2.08B	-19.8%
Dec 2010	$2.59B	-7.4%
Sep 2010	$2.80B	+3.4%
Jun 2010	$2.71B	+17.3%
Mar 2010	$2.31B	-5.8%
Dec 2009	$2.45B	+7.5%
Sep 2009	$2.28B	+2.0%
Jun 2009	$2.23B	-11.1%
Mar 2009	$2.51B	+10.9%
Dec 2008	$2.27B	+5.1%
Sep 2008	$2.16B	-2.4%
Jun 2008	$2.21B	+3.5%
Mar 2008	$2.13B	+3.9%
Dec 2007	$2.05B	+6.4%
Sep 2007	$1.93B	+11.6%
Jun 2007	$1.73B	-8.8%
Mar 2007	$1.90B	+7.3%
Dec 2006	$1.77B	-16.4%
Sep 2006	$2.11B	+8.8%
Jun 2006	$1.94B	+9.6%
Mar 2006	$1.77B	+7.8%
Dec 2005	$1.64B	+55.1%
Sep 2005	$1.06B	-13.5%
Jun 2005	$1.23B	-4.0%
Mar 2005	$1.28B	-18.9%
Dec 2004	$1.57B	-18.7%
Sep 2004	$1.94B	-1.6%
Jun 2004	$1.97B	+14.4%
Mar 2004	$1.72B	+22.3%
Dec 2003	$1.40B	-1.5%
Sep 2003	$1.43B	+19.0%
Jun 2003	$1.20B	+4.8%
Mar 2003	$1.14B	-7.6%
Dec 2002	$1.24B	-10.1%
Sep 2002	$1.38B	+5.0%
Jun 2002	$1.31B	-0.0%
Mar 2002	$1.31B	+12.0%
Dec 2001	$1.17B	-38.3%
Sep 2001	$1.90B	+40.4%
Jun 2001	$1.35B	+29.4%
Mar 2001	$1.04B	-6.2%
Dec 2000	$1.11B	>+9,900.0%
Sep 2000	$100.00	-100.0%
Jun 2000	$219.01M	-22.9%
Mar 2000	$284.19M	-

FAQ

What is the current TTM D&A of GSK?: As of today, GSK TTM D&A is $3.36B
What is GSK TTM D&A most recent change?: GSK TTM D&A was down -26.76% on June 30, 2026
What is 1-year change in GSK TTM D&A?: GSK TTM D&A is down -31.61% year-over-year
How far is GSK TTM D&A from its all-time high?: GSK TTM D&A is currently -43.56% below its historical high of $5.95B set on September 30, 2021
How does GSK TTM D&A rank versus sector peers?: GSK TTM D&A is higher than 98.86% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on October 28, 2026

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk